Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I'm keeping it on watch after taking profit yesterday. Opportunities for flips will be there. I did the right thing selling yest though as pps is much lower now.
NOW is the time to get in.... Look at Leap's website and all the other trials active / pending - those + the pending formalization of this merger = multiple BIG runs
Let the MCUR run begin. Great news and this is only one of many drugs that will have positive results. Merger approved and positive results. More to come. BUY BUY BUY
im scaling in as steady as i can
i guessing here but i expect same for 2017 finish date in feb.
I think they are waiting till 2017 to send out the PR. I'm taking this as a great buying opportunity!
VOTE: MERGER APPROVED http://ih.advfn.com/p.php?pid=nmona&article=73331173
Today should be the day of good news; Bull trend to the stratosphere should begin asap
Hardly any vol again today, and no reaction AH to the filing.
Been waiting on this one for a while, hope its ready to run up soon.
Had a great day Fri and hope for a continuation this week.
A little early vol compared to what we usually see here. Maybe its ready to move.
Got in with a starter on the pull back. Will add more later if necessary. Like the action here lately.
waiting for the $3 merger completion soon
* * $MCUR Video Chart 10-10-16 * *
Link to Video - click here to watch the technical chart video
i think we range until merger is complete
Think MCUR will keep climing? Thanks
CrAzy time and sale #'s happening spread is over .30
Just based on the influx of the $10 mill cash
Leap Therapeutics Presents Positive Top-line Results of DKN-01 Combination Therapy for Cholangiocarcinoma at the European Society for Medical Oncology 2016 Congress
By Business Wire, October 08, 2016, 07:00:00 AM EDT
Read more: http://www.nasdaq.com/press-release/leap-therapeutics-presents-positive-topline-results-of-dkn01-combination-therapy-for-20161008-00019#ixzz4Mh7VfXPI
Im seeing 3.30 a share at reentry to Nasd
So are they looking @ 2,60 or $3.00 a share
anyone think this turd of a stock will recover back to $3.00??
They finally did the press release.
Dead in the water..no volume. I'm screwed on this one. Can't believe all the selling past two days considering most buys were above 2.00.
Macrocure Ltd. (MCUR) could have at least released a PR with the SEC link to the actual merger plans to show progress through the merger.
it really are upward bound from here, we just need to ride out the time wave.
All we can do is hope so.. But I think we will make some money off this bad boy soon enough!
Macrocure Ltd. GOOOOOO
Merger details out! See SEC docs below!
https://www.sec.gov/Archives/edgar/data/1606012/000117891316006385/0001178913-16-006385-index.htm
I would say good news! It shows progress of the merger for sure. I will get back to you with more once I look over the sec filings.
MCUR$$$$
Anyone know what this means? Got this from the latest report of foriegn issuer news sec filing on their website. Not sure what this means with regards to our MCUR shares. However the conversion part 1/10,000 makes me wonder if MCUR shares will be converted over at a 1 for 10,000 like a split of some sort? Or am i Reading this wrong? Is it talking about share price of the newly listed LEAP stock?
Just wanting to know if my shares will be reduced upon being converted over to LEAP stock or if I will still have the same amount of shares but it will have a different price calculation? As for the par value that is not the IPO, so I do not think the leap stock upon going public would be that low.
"
SECTION 1.05. Certificates of Incorporation and By-laws .
(a) The Amended and Restated Certificate of Incorporation of Leap (the “ Leap Charter ”) and the Amended and Restated By-laws of Leap (the “ Leap By-laws ”) shall each be amended and restated immediately prior to the Effective Time to read in the form of Exhibit B (the “ New Leap Charter ”) and Exhibit C (the “ New Leap By-laws ”), respectively, and the New Leap Charter and the New Leap By-laws shall be the certificate of incorporation and By-laws of Leap until thereafter changed or amended as provided therein or by applicable Law. Leap shall file the New Leap Charter with the Secretary of State of the State of Delaware in accordance with the relevant provisions of the DGCL. As a result of the amendment to the Leap Charter pursuant to this Section 1.05(a) , each share of common stock of Leap, par value $0.001 per share (the “ Leap Common Stock ”), issued and outstanding immediately prior to such amendment (including, without limitation, shares subject to then outstanding options) shall be converted (the “ Pre-Closing Leap Share Conversion ”) into a fraction of a share of Leap Common Stock equal to the quotient (calculated to the nearest 1/10,000 of a share) obtained by dividing (x) 6,500,000 by (y) the number of Pre-Split Outstanding Leap Shares, subject to adjustment in accordance with Section 6.23 of this Agreement (the “ Leap Share Conversion Ratio ”). In the event that the Leap Stock Options contemplated under Section 6.21 of this Agreement have not been granted at or prior to the time the Pre-Closing Leap Share Conversion becomes effective for any reason, then the 6,500,000 shares of Leap Common Stock referred to in the foregoing clause (x) shall be adjusted to a number of shares of Leap Common Stock such that, after giving effect to the Pre-Closing Leap Share Conversion and the grant of such Leap Stock Options following the Pre-Closing Leap Share Conversion, the Adjusted Outstanding Leap Shares immediately prior to the Effective Time shall be equal to 6,500,000, subject to further adjustment in accordance with Section 6.23 of this Agreement. No fractional shares of Leap Common Stock shall be issued in connection with the Pre-Closing Leap Share Conversion, and each holder of shares of Leap Common Stock converted pursuant to the Pre-Closing Leap Share Conversion who would otherwise have been entitled to receive a fraction of a share of Leap Common Stock shall receive cash in lieu thereof in accordance with the New Leap Charter.
"
Biotech Movers: Macrocure and CoLucid Pharmaceuticals http://marketexclusive.com/biotech-movers-7/25042/?icd1
Followers
|
12
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
234
|
Created
|
01/01/15
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |